Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 1 |
2019 | 2 |
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists.
Cancers (Basel). 2019 Jul 19;11(7):1014. doi: 10.3390/cancers11071014.
Cancers (Basel). 2019.
PMID: 31331108
Free PMC article.
Review.
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint.
Konieczny M, Musielak B, Kocik J, Skalniak L, Sala D, Czub M, Magiera-Mularz K, Rodriguez I, Myrcha M, Stec M, Siedlar M, Holak TA, Plewka J.
Konieczny M, et al. Among authors: kocik j.
J Med Chem. 2020 Oct 8;63(19):11271-11285. doi: 10.1021/acs.jmedchem.0c01260. Epub 2020 Sep 23.
J Med Chem. 2020.
PMID: 32936638
Free PMC article.
Item in Clipboard
Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint.
Magiera-Mularz K, Skalniak L, Zak KM, Musielak B, Rudzinska-Szostak E, Berlicki Ł, Kocik J, Grudnik P, Sala D, Zarganes-Tzitzikas T, Shaabani S, Dömling A, Dubin G, Holak TA.
Magiera-Mularz K, et al. Among authors: kocik j.
Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13732-13735. doi: 10.1002/anie.201707707. Epub 2017 Sep 26.
Angew Chem Int Ed Engl. 2017.
PMID: 28881104
Free PMC article.
Item in Clipboard
CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not?
Musielak B, Kocik J, Skalniak L, Magiera-Mularz K, Sala D, Czub M, Stec M, Siedlar M, Holak TA, Plewka J.
Musielak B, et al. Among authors: kocik j.
Molecules. 2019 Aug 1;24(15):2804. doi: 10.3390/molecules24152804.
Molecules. 2019.
PMID: 31374878
Free PMC article.
Item in Clipboard
Human and mouse PD-L1: similar molecular structure, but different druggability profiles.
Magiera-Mularz K, Kocik J, Musielak B, Plewka J, Sala D, Machula M, Grudnik P, Hajduk M, Czepiel M, Siedlar M, Holak TA, Skalniak L.
Magiera-Mularz K, et al. Among authors: kocik j.
iScience. 2020 Dec 24;24(1):101960. doi: 10.1016/j.isci.2020.101960. eCollection 2021 Jan 22.
iScience. 2020.
PMID: 33437940
Free PMC article.
Item in Clipboard
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells.
Skalniak L, Kocik J, Polak J, Skalniak A, Rak M, Wolnicka-Glubisz A, Holak TA.
Skalniak L, et al. Among authors: kocik j.
Cancers (Basel). 2018 Oct 24;10(11):396. doi: 10.3390/cancers10110396.
Cancers (Basel). 2018.
PMID: 30352966
Free PMC article.
Item in Clipboard
Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells.
Skalniak L, Zak KM, Guzik K, Magiera K, Musielak B, Pachota M, Szelazek B, Kocik J, Grudnik P, Tomala M, Krzanik S, Pyrc K, Dömling A, Dubin G, Holak TA.
Skalniak L, et al. Among authors: kocik j.
Oncotarget. 2017 Aug 7;8(42):72167-72181. doi: 10.18632/oncotarget.20050. eCollection 2017 Sep 22.
Oncotarget. 2017.
PMID: 29069777
Free PMC article.
Item in Clipboard
Cite
Cite